HistoryData
Julius Axelrod

Julius Axelrod

biochemistchemistneuroscientistpharmacologistscientist

Who was Julius Axelrod?

American biochemist (1912–2004)

Biographical data adapted from Wikipedia’s article on Julius Axelrod (CC BY-SA 4.0).

Born
New York City
Died
2004
Bethesda
Nationality
Zodiac Sign
Gemini

Biography

Julius Axelrod was born on May 30, 1912, in New York City to Jewish immigrants from Poland. He attended Seward Park High School and then City College of New York, where he got a Bachelor of Science degree in 1933. Despite being academically gifted, Axelrod faced multiple rejections from medical schools, which led him down an unconventional path in his scientific career. He started as a lab technician at New York University's Laboratory of Industrial Hygiene, where he gained practical chemical experience that would later become crucial for his research approach.

Axelrod's formal progress in science came later in his life. He spent two decades in different lab and government roles before earning his PhD in pharmacology from George Washington University Medical School in 1955, when he was 43. He did his doctoral research with Bernard Brodie at the National Heart Institute, part of the National Institutes of Health (NIH) in Bethesda, Maryland. Axelrod spent most of his career at the NIH, eventually leading the Section on Pharmacology in the Laboratory of Clinical Science at the National Institute of Mental Health.

His most notable scientific achievements focused on catecholamine neurotransmitters like epinephrine and norepinephrine, exploring how they're released, interact with cells, and are cleared from the synapse. Axelrod discovered the reuptake process, where nerve terminals recapture neurotransmitters after release, significantly impacting the understanding of nervous system regulation. He also identified the enzyme catechol-O-methyltransferase (COMT), essential for breaking down these neurotransmitters, paving the way for many psychiatric and cardiovascular medications.

In 1970, Axelrod was awarded a share of the Nobel Prize in Physiology or Medicine with Bernard Katz and Ulf von Euler for his research on neurotransmitter release and inactivation. The Nobel Committee highlighted his work on catecholamines' storage, release, and reuptake mechanisms. Axelrod also explored the pineal gland, shedding light on melatonin production and its relation to light and dark cycles, connecting the gland to circadian rhythm regulation.

Throughout his career, Axelrod received numerous honors, including the Canada Gairdner International Award in 1967, the Schmiedeberg Badge in 1978, a Foreign Member of the Royal Society election in 1979, an honorary doctorate from the University of Paris-XI in 1982, the Bristol-Myers Squibb Award for Distinguished Achievement in Neuroscience Research in 1989, the Ralph W. Gerard Prize in 1992, and a fellowship in the American Academy of Arts and Sciences. He continued to work at the NIH well into his later years and passed away in Bethesda, Maryland, on December 29, 2004, at 92.

Before Fame

Growing up on the Lower East Side of Manhattan, Axelrod was part of a working-class immigrant community in the early twentieth century. In this environment, higher education was seen as a way to move up in the world, though jobs were still limited by economic and social hurdles. After finishing his undergraduate degree during the Great Depression, he found that medical school was off-limits due to quota systems that many American universities used to limit Jewish enrollment.

Instead of leaving science behind, Axelrod worked for years as a lab technician, gaining practical experience in chemical analysis that many formally trained researchers didn't have. This hands-on work, paired with evening classes at New York University, quietly laid the groundwork for his later theoretical contributions. Moving to the NIH and working under Bernard Brodie gave him the support and stimulating environment he needed to finally pursue independent, high-level research.

Key Achievements

  • Discovered the mechanism of neurotransmitter reuptake at sympathetic nerve terminals, fundamentally changing the understanding of synaptic transmission.
  • Identified catechol-O-methyltransferase (COMT), a key enzyme in the metabolic degradation of catecholamine neurotransmitters.
  • Shared the 1970 Nobel Prize in Physiology or Medicine for his work on the storage, release, and inactivation of catecholamine neurotransmitters.
  • Elucidated the role of the pineal gland in regulating melatonin production in response to light-dark cycles, advancing the science of circadian biology.
  • Received the Canada Gairdner International Award (1967) and was elected a Foreign Member of the Royal Society (1979), among numerous other international honors.

Did You Know?

  • 01.Axelrod earned his PhD at the age of 43, making him one of the older recipients of a first doctorate to subsequently win a Nobel Prize in the sciences.
  • 02.During his years as a laboratory technician, Axelrod lost sight in his left eye due to a laboratory accident involving an ammonia explosion, yet continued his bench work throughout his career.
  • 03.His identification of catechol-O-methyltransferase (COMT) as a neurotransmitter-metabolizing enzyme directly influenced the development of COMT inhibitor drugs later used in treating Parkinson's disease.
  • 04.Axelrod's research on the pineal gland helped establish that melatonin synthesis is controlled by the enzyme serotonin N-acetyltransferase, connecting light exposure directly to hormonal output.
  • 05.He was an outspoken advocate against the use of scientific research for military purposes and signed public statements opposing the Vietnam War while working as a federal government scientist.

Awards & Honors

AwardYearDetails
Nobel Prize in Physiology or Medicine1970for their discoveries concerning the humoral transmitters in the nerve terminals and the mechanism for their storage, release and inactivation
Canada Gairdner International Award1967
Schmiedeberg Badge1978
Foreign Member of the Royal Society1979
honorary doctorate from University of Paris-XI1982
Bristol-Myers Squibb Award for Distinguished Achievement in Neuroscience Research1989
Ralph W. Gerard Prize1992
Fellow of the American Academy of Arts and Sciences

Nobel Prizes